Current Treatment Practices for Adult Patients with Constipation in Japan

Background: The prevalence of constipation in Japan is estimated to be 2-5%. Constipation is a disease found in older adults. In particular, Japan is an aging society, with 65% of men and 80.5% of women aged 65 years or older accounting for the majority of its population. Chronic constipation may be associated with survival, cardiovascular events, decreased quality of life, and death. This study summarizes the recent findings regarding constipation treatment practice in Japan. Summary: Until recently, the diagnosis of constipation was mainly based on medical interviews; however, with the recent development of handheld ultrasound devices, both physicians and nurses can easily and objectively diagnose fecal retention. Magnesium oxide and stimulant laxatives have been the mainstay treatments; however, since 2012, more than five new drugs for treating constipation have become available in Japan. Key Messages: Magnesium oxide is less effective in patients who use acid-secretion inhibitors and patients who have undergone total gastrectomy and should be cared for hypermagnesemia. In addition, regular use of stimulant laxatives may lead to colonic inertia and decreased bowel movements; therefore, they should be used only occasionally. The following is an overview of the different uses of conventional and newer laxatives for treating constipation.

Automated summary

This article summarizes the recent findings regarding constipation treatment practice in Japan. Constipation is common in older adults, and Japan is an aging society with a majority of its population being 65 years or older. Diagnosing constipation used to be based on medical interviews, but with the development of handheld ultrasound devices, healthcare professionals can now easily and objectively diagnose fecal retention. In addition to magnesium oxide and stimulant laxatives, Japan has introduced five new drugs for treating constipation since 2012.